Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.80646702 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.80646702 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.37807384 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.46795970 |
5 | ribosomal small subunit assembly (GO:0000028) | 5.07618913 |
6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.96432030 |
7 | negative regulation of cell killing (GO:0031342) | 4.83105020 |
8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.83105020 |
9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.60016615 |
10 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.35635985 |
11 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.14453927 |
12 | DNA deamination (GO:0045006) | 3.98863425 |
13 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.91369981 |
14 | immunoglobulin mediated immune response (GO:0016064) | 3.87082302 |
15 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.86243696 |
16 | response to interferon-beta (GO:0035456) | 3.86022700 |
17 | cellular response to interferon-beta (GO:0035458) | 3.80893107 |
18 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.71369854 |
19 | * cellular response to type I interferon (GO:0071357) | 3.69913326 |
20 | * type I interferon signaling pathway (GO:0060337) | 3.69913326 |
21 | * response to type I interferon (GO:0034340) | 3.69543551 |
22 | detection of bacterium (GO:0016045) | 3.69462460 |
23 | cytidine deamination (GO:0009972) | 3.69359488 |
24 | cytidine metabolic process (GO:0046087) | 3.69359488 |
25 | cytidine catabolic process (GO:0006216) | 3.69359488 |
26 | viral transcription (GO:0019083) | 3.63986042 |
27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.63459833 |
28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.63459833 |
29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.63459833 |
30 | modulation by symbiont of host immune response (GO:0052553) | 3.63459833 |
31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.63459833 |
32 | modulation by symbiont of host defense response (GO:0052031) | 3.63459833 |
33 | positive regulation of B cell differentiation (GO:0045579) | 3.62040197 |
34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.59937724 |
35 | detection of other organism (GO:0098543) | 3.59323819 |
36 | negative thymic T cell selection (GO:0045060) | 3.49537109 |
37 | NIK/NF-kappaB signaling (GO:0038061) | 3.48615153 |
38 | regulation of T cell tolerance induction (GO:0002664) | 3.47591740 |
39 | mast cell activation (GO:0045576) | 3.47099255 |
40 | translational termination (GO:0006415) | 3.46661268 |
41 | cellular response to zinc ion (GO:0071294) | 3.45343878 |
42 | negative T cell selection (GO:0043383) | 3.45197832 |
43 | macrophage activation involved in immune response (GO:0002281) | 3.44683055 |
44 | leukocyte aggregation (GO:0070486) | 3.44327960 |
45 | regulation of B cell differentiation (GO:0045577) | 3.42743640 |
46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.38781563 |
47 | B cell mediated immunity (GO:0019724) | 3.36773182 |
48 | positive T cell selection (GO:0043368) | 3.35844213 |
49 | negative regulation of phagocytosis (GO:0050765) | 3.34445457 |
50 | defense response to protozoan (GO:0042832) | 3.34185989 |
51 | regulation of tolerance induction (GO:0002643) | 3.34092043 |
52 | regulation of regulatory T cell differentiation (GO:0045589) | 3.32666512 |
53 | T cell migration (GO:0072678) | 3.32389851 |
54 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.30253269 |
55 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.30253269 |
56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.29969401 |
57 | negative regulation of interleukin-12 production (GO:0032695) | 3.29378357 |
58 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.28958718 |
59 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.23816659 |
60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.21517677 |
61 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.19900089 |
62 | myeloid dendritic cell activation (GO:0001773) | 3.18982512 |
63 | B cell receptor signaling pathway (GO:0050853) | 3.18893654 |
64 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.18049923 |
65 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.18036468 |
66 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.15380746 |
67 | response to protozoan (GO:0001562) | 3.14703115 |
68 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.13920095 |
69 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.13676634 |
70 | response to peptidoglycan (GO:0032494) | 3.11230523 |
71 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.09931311 |
72 | positive regulation of tolerance induction (GO:0002645) | 3.08807305 |
73 | ribosomal small subunit biogenesis (GO:0042274) | 3.08796073 |
74 | positive regulation of antigen processing and presentation (GO:0002579) | 3.07562523 |
75 | cotranslational protein targeting to membrane (GO:0006613) | 3.06193270 |
76 | cellular response to interferon-gamma (GO:0071346) | 3.05777996 |
77 | protein targeting to ER (GO:0045047) | 3.05278792 |
78 | myeloid cell activation involved in immune response (GO:0002275) | 3.02814573 |
79 | translational elongation (GO:0006414) | 3.01939977 |
80 | positive regulation of cell killing (GO:0031343) | 3.01218428 |
81 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00602664 |
82 | positive regulation of interferon-alpha production (GO:0032727) | 2.99331097 |
83 | T cell homeostasis (GO:0043029) | 2.99063554 |
84 | positive thymic T cell selection (GO:0045059) | 2.99043364 |
85 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.98512369 |
86 | interferon-gamma production (GO:0032609) | 2.98002368 |
87 | response to interferon-alpha (GO:0035455) | 2.97914112 |
88 | neutrophil activation involved in immune response (GO:0002283) | 2.97878137 |
89 | response to interleukin-15 (GO:0070672) | 2.97527108 |
90 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.97189204 |
91 | regulation of necroptotic process (GO:0060544) | 2.93782767 |
92 | regulation of cell killing (GO:0031341) | 2.93341945 |
93 | protein localization to endoplasmic reticulum (GO:0070972) | 2.91937145 |
94 | neutrophil activation (GO:0042119) | 2.91079742 |
95 | regulation of response to interferon-gamma (GO:0060330) | 2.90475701 |
96 | tolerance induction (GO:0002507) | 2.89217869 |
97 | respiratory burst (GO:0045730) | 2.88924490 |
98 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.88385012 |
99 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.86685291 |
100 | sequestering of actin monomers (GO:0042989) | 2.86459470 |
101 | lymphocyte migration (GO:0072676) | 2.86059203 |
102 | T cell receptor signaling pathway (GO:0050852) | 2.85978660 |
103 | regulation of RIG-I signaling pathway (GO:0039535) | 2.85642478 |
104 | response to interferon-gamma (GO:0034341) | 2.84314101 |
105 | regulation of interferon-alpha production (GO:0032647) | 2.83765502 |
106 | myeloid dendritic cell differentiation (GO:0043011) | 2.82619290 |
107 | detection of external biotic stimulus (GO:0098581) | 2.80942523 |
108 | regulation of antigen processing and presentation (GO:0002577) | 2.80578651 |
109 | cellular response to interleukin-15 (GO:0071350) | 2.80056148 |
110 | actin nucleation (GO:0045010) | 2.80051751 |
111 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.79187327 |
112 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.78128667 |
113 | negative regulation of innate immune response (GO:0045824) | 2.77684937 |
114 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.76395404 |
115 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.74966614 |
116 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.74907361 |
117 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.73683314 |
118 | viral life cycle (GO:0019058) | 2.73309545 |
119 | positive regulation of macrophage differentiation (GO:0045651) | 2.72072863 |
120 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.71606482 |
121 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.70999773 |
122 | thymic T cell selection (GO:0045061) | 2.70183726 |
123 | cellular response to exogenous dsRNA (GO:0071360) | 2.67382019 |
124 | positive regulation of lamellipodium assembly (GO:0010592) | 2.66394167 |
125 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.64998284 |
126 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.64789059 |
127 | telomere maintenance via recombination (GO:0000722) | 2.64443890 |
128 | mature B cell differentiation involved in immune response (GO:0002313) | 2.61298221 |
129 | natural killer cell activation (GO:0030101) | 2.60240237 |
130 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.60191048 |
131 | DNA strand elongation (GO:0022616) | 2.59654424 |
132 | lymph node development (GO:0048535) | 2.59013640 |
133 | maturation of SSU-rRNA (GO:0030490) | 2.58335377 |
134 | cellular protein complex disassembly (GO:0043624) | 2.56416535 |
135 | T cell costimulation (GO:0031295) | 2.56098562 |
136 | necroptotic process (GO:0070266) | 2.55307742 |
137 | mature B cell differentiation (GO:0002335) | 2.54990711 |
138 | lymphocyte homeostasis (GO:0002260) | 2.54774770 |
139 | lymphocyte costimulation (GO:0031294) | 2.54374240 |
140 | negative regulation of viral genome replication (GO:0045071) | 2.54291553 |
141 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.54031096 |
142 | mast cell degranulation (GO:0043303) | 2.53873084 |
143 | mast cell activation involved in immune response (GO:0002279) | 2.53873084 |
144 | T cell selection (GO:0045058) | 2.51375903 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.23792385 |
2 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.93674891 |
3 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.01702744 |
4 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.63860192 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.49054175 |
6 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.14072269 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13144965 |
8 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.03964491 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.00329418 |
10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.79453133 |
11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.68485970 |
12 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.65823357 |
13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.54796630 |
14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51928264 |
15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.50142299 |
16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.46760511 |
17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37838305 |
18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37758618 |
19 | MYC_22102868_ChIP-Seq_BL_Human | 2.37675935 |
20 | MYB_26560356_Chip-Seq_TH2_Human | 2.26739277 |
21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.25639862 |
22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25496093 |
23 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.19020628 |
24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.16494758 |
25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.14494748 |
26 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13582382 |
27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09526348 |
28 | * MAF_26560356_Chip-Seq_TH1_Human | 2.06682573 |
29 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05761424 |
30 | MYB_26560356_Chip-Seq_TH1_Human | 1.95647669 |
31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.91565819 |
32 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.87943145 |
33 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.85853828 |
34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.84953494 |
35 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83694029 |
36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83253968 |
37 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79686727 |
38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79678922 |
39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.77795893 |
40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77679509 |
41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74577178 |
42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.74476364 |
43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72598517 |
44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68853923 |
45 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.68719162 |
46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.68464084 |
47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.66998972 |
48 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.65576861 |
49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64085385 |
50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.63554786 |
51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60847204 |
52 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.55605910 |
53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48464885 |
54 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.46971949 |
55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46140851 |
56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44841922 |
57 | MAF_26560356_Chip-Seq_TH2_Human | 1.44676759 |
58 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.42757376 |
59 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.42417970 |
60 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41185481 |
61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.40401166 |
62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34909027 |
63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.33489972 |
64 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32620948 |
65 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.30960589 |
66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30728157 |
67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.30456876 |
68 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.28552417 |
69 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.28376832 |
70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25936298 |
71 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23242278 |
72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22586964 |
73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21469647 |
74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.21012305 |
75 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.19737526 |
76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17169939 |
77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16854674 |
78 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.16220350 |
79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16002581 |
80 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.14971156 |
81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11020220 |
82 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.10771778 |
83 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.10046601 |
84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09797365 |
85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09663650 |
86 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08848499 |
87 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.08520244 |
88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08324289 |
89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07276493 |
90 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.07113365 |
91 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.06573822 |
92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06065969 |
93 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03340716 |
94 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.02984051 |
95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01086949 |
96 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01083786 |
97 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.00373356 |
98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99823570 |
99 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99510329 |
100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98781456 |
101 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98285097 |
102 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.96940458 |
103 | P300_27268052_Chip-Seq_Bcells_Human | 0.96537100 |
104 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94849794 |
105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94226175 |
106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94178480 |
107 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94066053 |
108 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93953364 |
109 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93767982 |
110 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93232712 |
111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93129594 |
112 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93093075 |
113 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92520632 |
114 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91766756 |
115 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91502262 |
116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90270526 |
117 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.89404234 |
118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87383817 |
119 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86021793 |
120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85749198 |
121 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84430130 |
122 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.81745590 |
123 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81318149 |
124 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80693135 |
125 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.80472418 |
126 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.79931610 |
127 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.76440005 |
128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.76308076 |
129 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.75666530 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0001835_abnormal_antigen_presentation | 4.62501237 |
2 | MP0005671_abnormal_response_to | 3.77442294 |
3 | MP0000685_abnormal_immune_system | 3.56717664 |
4 | MP0009785_altered_susceptibility_to | 3.47488364 |
5 | MP0003763_abnormal_thymus_physiology | 3.21303488 |
6 | MP0001800_abnormal_humoral_immune | 3.03591696 |
7 | MP0005025_abnormal_response_to | 2.91444705 |
8 | MP0005000_abnormal_immune_tolerance | 2.87470089 |
9 | MP0005387_immune_system_phenotype | 2.85828904 |
10 | MP0001790_abnormal_immune_system | 2.85828904 |
11 | MP0002396_abnormal_hematopoietic_system | 2.82361702 |
12 | MP0003436_decreased_susceptibility_to | 2.76391893 |
13 | MP0002452_abnormal_antigen_presenting | 2.74037017 |
14 | MP0002723_abnormal_immune_serum | 2.71998684 |
15 | MP0002148_abnormal_hypersensitivity_rea | 2.71645813 |
16 | MP0002420_abnormal_adaptive_immunity | 2.68346977 |
17 | MP0001819_abnormal_immune_cell | 2.66916260 |
18 | MP0003724_increased_susceptibility_to | 2.56863261 |
19 | MP0002398_abnormal_bone_marrow | 2.51314714 |
20 | MP0002419_abnormal_innate_immunity | 2.44715755 |
21 | * MP0002166_altered_tumor_susceptibility | 2.33912927 |
22 | * MP0000716_abnormal_immune_system | 2.26658526 |
23 | MP0009333_abnormal_splenocyte_physiolog | 2.17417513 |
24 | MP0001853_heart_inflammation | 2.13873082 |
25 | MP0005464_abnormal_platelet_physiology | 2.13136689 |
26 | MP0002405_respiratory_system_inflammati | 2.07230717 |
27 | MP0000689_abnormal_spleen_morphology | 2.07209751 |
28 | MP0010155_abnormal_intestine_physiology | 2.05146387 |
29 | MP0006082_CNS_inflammation | 2.03762386 |
30 | MP0002722_abnormal_immune_system | 2.02438386 |
31 | * MP0002006_tumorigenesis | 2.00276222 |
32 | * MP0002429_abnormal_blood_cell | 1.94980793 |
33 | MP0001873_stomach_inflammation | 1.93159820 |
34 | MP0001845_abnormal_inflammatory_respons | 1.78319091 |
35 | MP0005397_hematopoietic_system_phenotyp | 1.76450028 |
36 | MP0001545_abnormal_hematopoietic_system | 1.76450028 |
37 | MP0004808_abnormal_hematopoietic_stem | 1.72372834 |
38 | MP0004947_skin_inflammation | 1.69440127 |
39 | MP0004510_myositis | 1.68290539 |
40 | MP0000703_abnormal_thymus_morphology | 1.68224975 |
41 | MP0003866_abnormal_defecation | 1.62895862 |
42 | MP0000490_abnormal_crypts_of | 1.59379110 |
43 | MP0003303_peritoneal_inflammation | 1.58572778 |
44 | MP0005174_abnormal_tail_pigmentation | 1.56854618 |
45 | MP0005075_abnormal_melanosome_morpholog | 1.53022844 |
46 | MP0008469_abnormal_protein_level | 1.51769139 |
47 | MP0000465_gastrointestinal_hemorrhage | 1.48117610 |
48 | MP0008057_abnormal_DNA_replication | 1.44198806 |
49 | MP0003693_abnormal_embryo_hatching | 1.38485009 |
50 | MP0003806_abnormal_nucleotide_metabolis | 1.37947911 |
51 | MP0000858_altered_metastatic_potential | 1.36919200 |
52 | MP0005310_abnormal_salivary_gland | 1.36492608 |
53 | MP0002933_joint_inflammation | 1.29631637 |
54 | MP0005360_urolithiasis | 1.28085411 |
55 | MP0001533_abnormal_skeleton_physiology | 1.27380888 |
56 | MP0003300_gastrointestinal_ulcer | 1.27317433 |
57 | MP0010094_abnormal_chromosome_stability | 1.19065157 |
58 | MP0002019_abnormal_tumor_incidence | 1.18689365 |
59 | MP0009764_decreased_sensitivity_to | 1.12038940 |
60 | MP0003448_altered_tumor_morphology | 1.07850335 |
61 | MP0002095_abnormal_skin_pigmentation | 1.06433821 |
62 | MP0003077_abnormal_cell_cycle | 1.04273717 |
63 | MP0003191_abnormal_cellular_cholesterol | 1.02302902 |
64 | MP0008007_abnormal_cellular_replicative | 1.00315143 |
65 | MP0000343_altered_response_to | 0.95454274 |
66 | MP0005058_abnormal_lysosome_morphology | 0.95445460 |
67 | MP0002132_abnormal_respiratory_system | 0.94996922 |
68 | MP0009278_abnormal_bone_marrow | 0.94978210 |
69 | MP0002277_abnormal_respiratory_mucosa | 0.94513589 |
70 | MP0010352_gastrointestinal_tract_polyps | 0.92839740 |
71 | MP0008058_abnormal_DNA_repair | 0.91255569 |
72 | MP0005451_abnormal_body_composition | 0.90560460 |
73 | MP0003172_abnormal_lysosome_physiology | 0.90071426 |
74 | MP0003186_abnormal_redox_activity | 0.88132696 |
75 | MP0009763_increased_sensitivity_to | 0.87776525 |
76 | MP0003045_fibrosis | 0.87234725 |
77 | MP0000015_abnormal_ear_pigmentation | 0.86512028 |
78 | MP0004957_abnormal_blastocyst_morpholog | 0.81127744 |
79 | MP0002139_abnormal_hepatobiliary_system | 0.78431151 |
80 | MP0010307_abnormal_tumor_latency | 0.76877952 |
81 | MP0003252_abnormal_bile_duct | 0.75253097 |
82 | MP0002138_abnormal_hepatobiliary_system | 0.75159072 |
83 | MP0001851_eye_inflammation | 0.71447832 |
84 | MP0004381_abnormal_hair_follicle | 0.71315425 |
85 | MP0000313_abnormal_cell_death | 0.70741181 |
86 | MP0005165_increased_susceptibility_to | 0.70085963 |
87 | MP0003111_abnormal_nucleus_morphology | 0.69335598 |
88 | MP0002998_abnormal_bone_remodeling | 0.68667345 |
89 | MP0005390_skeleton_phenotype | 0.68576444 |
90 | MP0008260_abnormal_autophagy | 0.67470452 |
91 | MP0001663_abnormal_digestive_system | 0.67120132 |
92 | MP0009379_abnormal_foot_pigmentation | 0.66077625 |
93 | MP0000604_amyloidosis | 0.65704873 |
94 | MP0008004_abnormal_stomach_pH | 0.64759837 |
95 | MP0001348_abnormal_lacrimal_gland | 0.64601448 |
96 | MP0003795_abnormal_bone_structure | 0.64546482 |
97 | MP0004883_abnormal_blood_vessel | 0.64510825 |
98 | MP0006054_spinal_hemorrhage | 0.64481142 |
99 | MP0000371_diluted_coat_color | 0.63305637 |
100 | MP0009643_abnormal_urine_homeostasis | 0.62765256 |
101 | MP0005164_abnormal_response_to | 0.62503156 |
102 | MP0009840_abnormal_foam_cell | 0.62271992 |
103 | MP0002693_abnormal_pancreas_physiology | 0.61332337 |
104 | MP0004782_abnormal_surfactant_physiolog | 0.60405220 |
105 | MP0003943_abnormal_hepatobiliary_system | 0.58990654 |
106 | MP0000609_abnormal_liver_physiology | 0.57548889 |
107 | MP0000477_abnormal_intestine_morphology | 0.57428805 |
108 | MP0000249_abnormal_blood_vessel | 0.56979756 |
109 | MP0009765_abnormal_xenobiotic_induced | 0.55971563 |
110 | MP0005319_abnormal_enzyme/_coenzyme | 0.55914936 |
111 | MP0003075_altered_response_to | 0.55117118 |
112 | MP0005166_decreased_susceptibility_to | 0.54907275 |
113 | MP0000598_abnormal_liver_morphology | 0.54588244 |
114 | MP0008875_abnormal_xenobiotic_pharmacok | 0.54295821 |
115 | MP0003183_abnormal_peptide_metabolism | 0.53974994 |
116 | MP0003828_pulmonary_edema | 0.53206416 |
117 | MP0008873_increased_physiological_sensi | 0.52967165 |
118 | MP0005381_digestive/alimentary_phenotyp | 0.52876158 |
119 | MP0002136_abnormal_kidney_physiology | 0.52822068 |
120 | MP0003656_abnormal_erythrocyte_physiolo | 0.52748447 |
121 | MP0005377_hearing/vestibular/ear_phenot | 0.52571918 |
122 | MP0003878_abnormal_ear_physiology | 0.52571918 |
123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51781910 |
124 | MP0002009_preneoplasia | 0.51226212 |
125 | MP0005085_abnormal_gallbladder_physiolo | 0.49296308 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Chronic otitis media (HP:0000389) | 5.38401993 |
2 | Recurrent bronchitis (HP:0002837) | 4.74140669 |
3 | Recurrent abscess formation (HP:0002722) | 4.61135139 |
4 | IgM deficiency (HP:0002850) | 4.59699480 |
5 | Myositis (HP:0100614) | 4.46340860 |
6 | Eczematoid dermatitis (HP:0000976) | 4.38577053 |
7 | Thrombocytosis (HP:0001894) | 4.28535616 |
8 | Recurrent bacterial skin infections (HP:0005406) | 4.10528070 |
9 | * Elevated erythrocyte sedimentation rate (HP:0003565) | 4.03121822 |
10 | Recurrent viral infections (HP:0004429) | 3.99654877 |
11 | Recurrent fungal infections (HP:0002841) | 3.99254937 |
12 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.69329899 |
13 | Recurrent cutaneous fungal infections (HP:0011370) | 3.69329899 |
14 | Nasal polyposis (HP:0100582) | 3.68175422 |
15 | Abnormality of T cells (HP:0002843) | 3.67387400 |
16 | Abnormality of T cell physiology (HP:0011840) | 3.63158795 |
17 | Panhypogammaglobulinemia (HP:0003139) | 3.55736355 |
18 | IgG deficiency (HP:0004315) | 3.54819380 |
19 | Agammaglobulinemia (HP:0004432) | 3.44340640 |
20 | Abnormality of T cell number (HP:0011839) | 3.43408194 |
21 | Abnormality of the nasal mucosa (HP:0000433) | 3.42076664 |
22 | Recurrent skin infections (HP:0001581) | 3.39707841 |
23 | T lymphocytopenia (HP:0005403) | 3.39287701 |
24 | Meningitis (HP:0001287) | 3.37058932 |
25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.31597051 |
26 | Petechiae (HP:0000967) | 3.26873048 |
27 | Severe combined immunodeficiency (HP:0004430) | 3.25703968 |
28 | Vasculitis (HP:0002633) | 3.18441503 |
29 | Abnormality of B cell number (HP:0010975) | 3.17514920 |
30 | B lymphocytopenia (HP:0010976) | 3.17514920 |
31 | Mediastinal lymphadenopathy (HP:0100721) | 3.14688853 |
32 | Thyroiditis (HP:0100646) | 3.12647460 |
33 | Lymphopenia (HP:0001888) | 3.12167430 |
34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.09683780 |
35 | Combined immunodeficiency (HP:0005387) | 3.06959608 |
36 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.05988556 |
37 | Abnormal number of erythroid precursors (HP:0012131) | 3.05522365 |
38 | Autoimmune thrombocytopenia (HP:0001973) | 3.05409780 |
39 | Chronic sinusitis (HP:0011109) | 2.97446020 |
40 | Reticulocytopenia (HP:0001896) | 2.95057382 |
41 | Orchitis (HP:0100796) | 2.91725134 |
42 | Increased IgM level (HP:0003496) | 2.90251473 |
43 | Cellulitis (HP:0100658) | 2.86603097 |
44 | Autoimmune hemolytic anemia (HP:0001890) | 2.83096952 |
45 | Obstructive lung disease (HP:0006536) | 2.81253906 |
46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.81253906 |
47 | Pustule (HP:0200039) | 2.80022963 |
48 | Abnormality of macrophages (HP:0004311) | 2.80022562 |
49 | Retrobulbar optic neuritis (HP:0100654) | 2.78032253 |
50 | Optic neuritis (HP:0100653) | 2.78032253 |
51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76989914 |
52 | Inflammation of the large intestine (HP:0002037) | 2.75481315 |
53 | Gastrointestinal inflammation (HP:0004386) | 2.74957873 |
54 | Interstitial pulmonary disease (HP:0006530) | 2.72522884 |
55 | Chronic diarrhea (HP:0002028) | 2.69157500 |
56 | Stomatitis (HP:0010280) | 2.69010682 |
57 | Bronchitis (HP:0012387) | 2.67765059 |
58 | Aplastic anemia (HP:0001915) | 2.67564891 |
59 | Keratoconjunctivitis (HP:0001096) | 2.67279127 |
60 | Spontaneous hematomas (HP:0007420) | 2.66477093 |
61 | Gastrointestinal stroma tumor (HP:0100723) | 2.64029213 |
62 | Recurrent sinusitis (HP:0011108) | 2.62549800 |
63 | Hypoplasia of the thymus (HP:0000778) | 2.62395326 |
64 | Abnormality of eosinophils (HP:0001879) | 2.60467779 |
65 | Lymphoma (HP:0002665) | 2.60182494 |
66 | IgA deficiency (HP:0002720) | 2.59894817 |
67 | Leukocytosis (HP:0001974) | 2.59245500 |
68 | Granulocytopenia (HP:0001913) | 2.56310447 |
69 | Eosinophilia (HP:0001880) | 2.53899984 |
70 | Prolonged bleeding time (HP:0003010) | 2.53752258 |
71 | Systemic lupus erythematosus (HP:0002725) | 2.51973052 |
72 | Hemoptysis (HP:0002105) | 2.50218218 |
73 | Abnormality of the pleura (HP:0002103) | 2.47429182 |
74 | Colitis (HP:0002583) | 2.47393283 |
75 | Epistaxis (HP:0000421) | 2.46180645 |
76 | Encephalitis (HP:0002383) | 2.45984398 |
77 | Abnormality of the prostate (HP:0008775) | 2.44194466 |
78 | Joint swelling (HP:0001386) | 2.43797235 |
79 | Gangrene (HP:0100758) | 2.40965505 |
80 | Reduced antithrombin III activity (HP:0001976) | 2.35316557 |
81 | * Hypergammaglobulinemia (HP:0010702) | 2.31676568 |
82 | Acute hepatic failure (HP:0006554) | 2.30278808 |
83 | Pulmonary infiltrates (HP:0002113) | 2.29962572 |
84 | Vacuolated lymphocytes (HP:0001922) | 2.29223001 |
85 | Pulmonary embolism (HP:0002204) | 2.28690856 |
86 | Increased IgE level (HP:0003212) | 2.28539628 |
87 | Hypoproteinemia (HP:0003075) | 2.28178792 |
88 | Poikiloderma (HP:0001029) | 2.27680469 |
89 | Increased serum ferritin (HP:0003281) | 2.27151949 |
90 | Anorexia (HP:0002039) | 2.26469074 |
91 | * Skin rash (HP:0000988) | 2.25143443 |
92 | Pallor (HP:0000980) | 2.24153952 |
93 | Recurrent pneumonia (HP:0006532) | 2.21476660 |
94 | Gingival bleeding (HP:0000225) | 2.18866805 |
95 | Recurrent lower respiratory tract infections (HP:0002783) | 2.18852842 |
96 | Periodontitis (HP:0000704) | 2.17929951 |
97 | Osteomyelitis (HP:0002754) | 2.14651505 |
98 | Emphysema (HP:0002097) | 2.14005398 |
99 | Skin ulcer (HP:0200042) | 2.12641950 |
100 | Gingivitis (HP:0000230) | 2.11288316 |
101 | Hepatosplenomegaly (HP:0001433) | 2.10774008 |
102 | Arterial thrombosis (HP:0004420) | 2.10770654 |
103 | Purpura (HP:0000979) | 2.08659444 |
104 | Neutropenia (HP:0001875) | 2.08000338 |
105 | Keratoconjunctivitis sicca (HP:0001097) | 2.07932195 |
106 | Abnormal platelet function (HP:0011869) | 2.06780103 |
107 | Impaired platelet aggregation (HP:0003540) | 2.06780103 |
108 | Verrucae (HP:0200043) | 2.05926275 |
109 | Papilloma (HP:0012740) | 2.05926275 |
110 | Type I transferrin isoform profile (HP:0003642) | 2.03305862 |
111 | Abnormality of iron homeostasis (HP:0011031) | 2.02344906 |
112 | Urticaria (HP:0001025) | 2.01306076 |
113 | Restrictive lung disease (HP:0002091) | 2.00109469 |
114 | * Arthralgia (HP:0002829) | 1.97824929 |
115 | Gastrointestinal infarctions (HP:0005244) | 1.95848314 |
116 | Chest pain (HP:0100749) | 1.95812557 |
117 | Sepsis (HP:0100806) | 1.94035889 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.69127603 |
2 | KIT | 3.11095097 |
3 | TXK | 3.00484088 |
4 | TBK1 | 2.78710584 |
5 | TYK2 | 2.78660060 |
6 | BLK | 2.77902697 |
7 | IKBKE | 2.77368186 |
8 | NME2 | 2.62015480 |
9 | JAK3 | 2.59800088 |
10 | ZAP70 | 2.40244304 |
11 | MAP3K14 | 2.34729833 |
12 | TEC | 2.25834481 |
13 | IRAK4 | 2.25201444 |
14 | BTK | 2.16827059 |
15 | KDR | 2.08767298 |
16 | SYK | 1.89003407 |
17 | GRK7 | 1.88443921 |
18 | CSF1R | 1.84060320 |
19 | FGFR4 | 1.79555415 |
20 | FLT3 | 1.70200616 |
21 | STK16 | 1.68715502 |
22 | PIM2 | 1.67740603 |
23 | BMPR2 | 1.67520074 |
24 | IKBKB | 1.57715459 |
25 | JAK1 | 1.47036639 |
26 | TESK2 | 1.46028830 |
27 | LCK | 1.42590622 |
28 | ITK | 1.40293372 |
29 | MAP3K12 | 1.37288889 |
30 | NLK | 1.33579979 |
31 | ERN1 | 1.32677258 |
32 | PRPF4B | 1.29934410 |
33 | EEF2K | 1.25599246 |
34 | LYN | 1.24934951 |
35 | MAP2K3 | 1.20846815 |
36 | ACVR1B | 1.20184276 |
37 | STK10 | 1.18975237 |
38 | GRK6 | 1.18751865 |
39 | MOS | 1.17696855 |
40 | TGFBR1 | 1.16574082 |
41 | FES | 1.16098143 |
42 | LRRK2 | 1.16043884 |
43 | FGFR3 | 1.15196973 |
44 | RPS6KA4 | 1.10894793 |
45 | HCK | 1.04904332 |
46 | CLK1 | 1.04301536 |
47 | TAOK3 | 1.04131395 |
48 | MARK3 | 1.02276047 |
49 | PIM1 | 1.01044024 |
50 | IRAK3 | 0.98304214 |
51 | RIPK4 | 0.98145295 |
52 | CSK | 0.98097999 |
53 | MST4 | 0.97282289 |
54 | MAP3K3 | 0.95463333 |
55 | TGFBR2 | 0.94362637 |
56 | VRK2 | 0.94059689 |
57 | EIF2AK3 | 0.93749901 |
58 | VRK1 | 0.90870219 |
59 | SCYL2 | 0.90711276 |
60 | GRK5 | 0.89801738 |
61 | MAP3K13 | 0.89139644 |
62 | TAOK2 | 0.85860879 |
63 | BCKDK | 0.83999124 |
64 | PKN2 | 0.80251218 |
65 | SMG1 | 0.78595837 |
66 | CHUK | 0.78260745 |
67 | FGR | 0.78208597 |
68 | EIF2AK1 | 0.75729403 |
69 | WEE1 | 0.74739822 |
70 | CDC7 | 0.73771034 |
71 | PDK1 | 0.71947025 |
72 | MAP3K11 | 0.69620769 |
73 | RPS6KB2 | 0.69345781 |
74 | BUB1 | 0.68999410 |
75 | MAP3K10 | 0.68709376 |
76 | MATK | 0.68212537 |
77 | MAPK11 | 0.67152462 |
78 | CDK19 | 0.65771798 |
79 | STK4 | 0.63998540 |
80 | JAK2 | 0.63961931 |
81 | TESK1 | 0.62632808 |
82 | CDK4 | 0.61558504 |
83 | NEK9 | 0.61531939 |
84 | PIK3CG | 0.60019800 |
85 | MAP3K1 | 0.59452491 |
86 | ADRBK2 | 0.59108889 |
87 | TLK1 | 0.58623216 |
88 | TNK2 | 0.56722701 |
89 | ATR | 0.55930114 |
90 | HIPK2 | 0.55516065 |
91 | TAOK1 | 0.55492918 |
92 | MAP2K6 | 0.54033848 |
93 | NEK2 | 0.49401287 |
94 | EPHA3 | 0.48260051 |
95 | EIF2AK2 | 0.48164062 |
96 | FYN | 0.47905611 |
97 | PASK | 0.46106169 |
98 | RPS6KA6 | 0.43588909 |
99 | PRKCQ | 0.43583427 |
100 | MAP3K5 | 0.43362702 |
101 | MAPKAPK3 | 0.43114588 |
102 | TNIK | 0.41028844 |
103 | DAPK1 | 0.40120711 |
104 | SIK3 | 0.40002769 |
105 | PRKCD | 0.39259138 |
106 | MYLK | 0.38441261 |
107 | DYRK3 | 0.38355249 |
108 | MAPK4 | 0.38053040 |
109 | ILK | 0.37986621 |
110 | MAPK12 | 0.37919967 |
111 | BRSK2 | 0.37645590 |
112 | CDK7 | 0.36602375 |
113 | NUAK1 | 0.36597267 |
114 | ARAF | 0.35166820 |
115 | AURKB | 0.33644053 |
116 | PAK1 | 0.32847610 |
117 | EPHB1 | 0.32050342 |
118 | ABL1 | 0.31991506 |
119 | CDK8 | 0.31777161 |
120 | MAPKAPK2 | 0.31542980 |
121 | IRAK1 | 0.31464573 |
122 | CCNB1 | 0.30714395 |
123 | RPS6KA5 | 0.30584132 |
124 | MAP3K8 | 0.30320737 |
125 | TIE1 | 0.29584199 |
126 | CAMKK2 | 0.29033756 |
127 | IGF1R | 0.27477621 |
128 | PDPK1 | 0.27141637 |
129 | INSR | 0.26903735 |
130 | PTK6 | 0.24205872 |
131 | ZAK | 0.24168510 |
132 | DAPK3 | 0.22876317 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.10997821 |
2 | DNA replication_Homo sapiens_hsa03030 | 3.26239593 |
3 | Ribosome_Homo sapiens_hsa03010 | 3.02889211 |
4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.81581116 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.53993825 |
6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.43934535 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.38225956 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.34023936 |
9 | Measles_Homo sapiens_hsa05162 | 2.33536237 |
10 | Mismatch repair_Homo sapiens_hsa03430 | 2.30372066 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 2.16153264 |
12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10868246 |
13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.10212703 |
14 | Base excision repair_Homo sapiens_hsa03410 | 2.08298024 |
15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.95668717 |
16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.88830291 |
17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.85001410 |
18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84904671 |
19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.80922887 |
20 | * Proteasome_Homo sapiens_hsa03050 | 1.70396455 |
21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69399782 |
22 | Homologous recombination_Homo sapiens_hsa03440 | 1.64279684 |
23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62474521 |
24 | Legionellosis_Homo sapiens_hsa05134 | 1.53291263 |
25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.52356880 |
26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43484235 |
27 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.41223844 |
28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.37488534 |
29 | Influenza A_Homo sapiens_hsa05164 | 1.37432435 |
30 | Pertussis_Homo sapiens_hsa05133 | 1.34961581 |
31 | Asthma_Homo sapiens_hsa05310 | 1.32573032 |
32 | Spliceosome_Homo sapiens_hsa03040 | 1.30355853 |
33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.28307659 |
34 | Shigellosis_Homo sapiens_hsa05131 | 1.26665282 |
35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.25885990 |
36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19534776 |
37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18133440 |
38 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15987935 |
39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15288654 |
40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13468367 |
41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13274863 |
42 | Apoptosis_Homo sapiens_hsa04210 | 1.13115062 |
43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12283265 |
44 | Malaria_Homo sapiens_hsa05144 | 1.10924389 |
45 | Hepatitis B_Homo sapiens_hsa05161 | 1.10384671 |
46 | Tuberculosis_Homo sapiens_hsa05152 | 1.04807794 |
47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03990028 |
48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01039240 |
49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00322961 |
50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94512761 |
51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92975963 |
52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91542858 |
53 | Protein export_Homo sapiens_hsa03060 | 0.91278575 |
54 | RNA polymerase_Homo sapiens_hsa03020 | 0.89812626 |
55 | Salmonella infection_Homo sapiens_hsa05132 | 0.88603912 |
56 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.88540720 |
57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88310070 |
58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88234043 |
59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86947084 |
60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85324529 |
61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.84189635 |
62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83170576 |
63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82588394 |
64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.82341343 |
65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82278999 |
66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76093508 |
67 | RNA degradation_Homo sapiens_hsa03018 | 0.73463388 |
68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72131016 |
69 | Hepatitis C_Homo sapiens_hsa05160 | 0.69872379 |
70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67952491 |
71 | Platelet activation_Homo sapiens_hsa04611 | 0.67728545 |
72 | Cell cycle_Homo sapiens_hsa04110 | 0.66916870 |
73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66603262 |
74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.66330319 |
75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65898657 |
76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65291777 |
77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61882928 |
78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58851624 |
79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55445504 |
80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55349059 |
81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50835302 |
82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49154714 |
83 | Lysosome_Homo sapiens_hsa04142 | 0.48253960 |
84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45879076 |
85 | Purine metabolism_Homo sapiens_hsa00230 | 0.45059096 |
86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44905720 |
87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44664303 |
88 | RNA transport_Homo sapiens_hsa03013 | 0.44581116 |
89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44297914 |
90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44100973 |
91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42793201 |
92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42505415 |
93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40180821 |
94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39375804 |
95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38931531 |
96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38698841 |
97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37576108 |
98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36454570 |
99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35454836 |
100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33198307 |
101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30044060 |
102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27740564 |
103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.27235805 |
104 | Endocytosis_Homo sapiens_hsa04144 | 0.26437549 |
105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26333726 |
106 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.25885155 |
107 | Phagosome_Homo sapiens_hsa04145 | 0.24109435 |
108 | Alcoholism_Homo sapiens_hsa05034 | 0.23794874 |
109 | ABC transporters_Homo sapiens_hsa02010 | 0.22502501 |
110 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.20803570 |
111 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.17871541 |
112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16679401 |
113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.16111523 |
114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15578358 |
115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15192013 |
116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.13843499 |
117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.11289005 |
118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.11113129 |
119 | Mineral absorption_Homo sapiens_hsa04978 | 0.11066957 |
120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.09796222 |
121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.09444032 |
122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.09111450 |
123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09061528 |
124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.08750681 |
125 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.08255162 |
126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.07112877 |
127 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.05885609 |
128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.05308624 |
129 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.04426611 |
130 | Peroxisome_Homo sapiens_hsa04146 | 0.03694239 |